spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Luca, M.
Right arrow Articles by Eberle, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Luca, M.
Right arrow Articles by Eberle, A. N.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Cell Science, Vol 105, Issue 4 1079-1084, Copyright © 1993 by Company of Biologists

JOURNAL ARTICLES

Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors

M De Luca, W Siegrist, S Bondanza, M Mathor, R Cancedda and AN Eberle
Laboratorio di Differenziamento Cellulare, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.

The combined action of cholera toxin (CT)-dependent activation of the adenylate cyclase signaling pathway, stimulation of protein kinase C, and activation of the tyrosine kinase activity of cell surface receptors and proto-oncogene products, have been shown to stimulate melanocyte proliferation. However, natural factors responsible for the optimal stimulation of normal human melanocyte growth, either isolated or co-cultured with keratinocytes, remain largely unknown. alpha MSH (alpha melanocyte stimulating hormone) has previously been shown to bind to murine and human melanoma cells and to stimulate their adenylate cyclase and tyrosinase activity. In contrast, very little is known about the presence and function of alpha MSH receptors in normal human melanocytes. We now report that alpha MSH: (i) binds to normal human melanocytes through a single class of high-affinity receptors; (ii) does not induce per se melanocytes to enter the S-phase of the cell cycle; (iii) does indeed stimulate melanocyte proliferation in a dose-dependent fashion; but its stimulatory effect requires bFGF and/or the activation of protein kinase C.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
K. A. Beaumont, S. L. Shekar, R. A. Newton, M. R. James, J. L. Stow, D. L. Duffy, and R. A. Sturm
Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles
Hum. Mol. Genet., September 15, 2007; 16(18): 2249 - 2260.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. Li, D.-N. Hu, H. Zhao, S. A. McCormick, J. J. Nordlund, and R. E. Boissy
Uveal Melanocytes Do Not Respond To or Express Receptors for {alpha}-Melanocyte-Stimulating Hormone.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4507 - 4512.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Bastiaens, J. ter Huurne, N. Gruis, W. Bergman, R. Westendorp, B.-J. Vermeer, and J.-N. B. Bavinck
The melanocortin-1-receptor gene is the major freckle gene
Hum. Mol. Genet., August 1, 2001; 10(16): 1701 - 1708.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
J Chluba-de Tapia, C Bagutti, R Cotti, and A. Eberle
Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene
J. Cell Sci., January 8, 1996; 109(8): 2023 - 2030.
[Abstract] [PDF]


© The Company of Biologists Ltd 1993